PDCD1 and neoplasm: As a result, CTLA-4 inhibits T cell activation within secondary lymphoid organs (Kurup et al., 2017), but PD-1/PD-L1 chiefly regulates T cell function within peripheral tissues and the tumor microenvironment (Pardoll, 2012).